Innovator IBD Breakout Opportunities ETF (BOUT)

Assets	$11.02M
Expense Ratio	0.85%
PE Ratio	28.57
Shares Out	300,000
Dividend (ttm)	$0.23
Dividend Yield	0.63%
Ex-Dividend Date	Dec 31, 2024
Payout Frequency	Semi-Annual
Payout Ratio	18.06%

Volume	985
Open	36.73
Previous Close	36.32
Day's Range	36.73 - 36.94
52-Week Low	31.08
52-Week High	42.41
Beta	1.07
Holdings	84
Inception Date	Sep 13, 2018

About BOUT

Fund Home Page

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is issued by Innovator.

• Asset Class: Equity
• Category: Mid-Cap Growth
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BOUT
• ETF Provider: Innovator
• Index Tracked: IBD Breakout Stocks Total Return

Top 10 Holdings

22.49% of assets

Name	Symbol	Weight
Royal Caribbean Cruises Ltd.	RCL	2.44%
Sportradar Group AG	SRAD	2.31%
Kyndryl Holdings, Inc.	KD	2.30%
Aramark	ARMK	2.24%
Emerson Electric Co.	EMR	2.24%
Autodesk, Inc.	ADSK	2.21%
Microsoft Corporation	MSFT	2.19%
Amer Sports, Inc.	AS	2.19%
Intuit Inc.	INTU	2.19%
MasTec, Inc.	MTZ	2.18%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 31, 2024	$0.22753	Jan 2, 2025
Jul 31, 2024	$0.0059	Aug 1, 2024
Dec 28, 2023	$0.43704	Jan 2, 2024
Dec 29, 2022	$0.39823	Jan 3, 2023
Dec 27, 2018	$0.0389	Jan 2, 2019

Performance

BOUT had a total return of 6.52% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.41%.